The procedure of thoracic endovascular aortic repair (TEVAR) represents one of the most revolutionary advances in the history of modern vascular surgery. From its inception, there has been a demonstrated decrease in intraoperative blood loss, hospital length of stay, recovery period, morbidity (especially spinal cord ischemia and pulmonary complications), and early mortality over traditional open repair. Some patients, previously thought to be unfit for open thoracic aortic aneurysm repair, are now considered candidates for TEVAR due to the decreased intra-and postoperative complication rate. A recent Medicare population study showed a significant increase in endovascular procedures and a decrease in open surgeries to treat thoracic aortic disease.